Bianca Weinstock-Guttman, Katelyn Kavak, Caila Vaughn, et al. Discontinuation of disease modifying therapies in stable MS patients is associated with disability progression regardless of age. AAN 2018, S8.008.
Genetisch risico hemochromatose geassocieerd met ijzerstapeling en bewegingsstoornissen
aug 2022 | Bewegingsstoornissen